Fig. 1From: Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and PortugalFollow-up program for the management of TTR gene mutation carriers. aThe prerequisites for offering predictive genetic testing should follow the local guidelines for genetic testing and diagnosis. ATTRv hereditary transthyretin, DMT disease-modifying treatment, TTR transthyretinBack to article page